ArticleNature communications2023
Differentiation of IL-26
Open access · goldAbstract read
In one paragraph
Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.1field-weighted citation impact, top 3% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed, 43 citations in OpenAlex.
- Single-cell RNA sequencing reveals the interaction of TREM2Immunologic research · 2026Article
- Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a large-scale prospective cohort study.Journal of global health · 2026Article
- Adaptation of mesenchymal stromal cells to culture on collagen-based bioscaffold.Journal of materials science. Materials in medicine · 2026Article
- A single-cell and spatial transcriptomic atlas of human tuberculous constrictive pericardium.EBioMedicine · 2026Article
- Inflammation drives TGFβ1 activation via the αvβ6 integrin-mechanotransduction pathway in human skin.iScience · 2026Article
- The expression patterns of Interleukin-26, Interleukin-35, and signal transducer and activator of transcription 1 in Type1 diabetes patients with diabetic nephropathy.Molecular biology reports · 2026Article
- Advances in Bioprinting to Model Immune-Mediated Skin Diseases.Advanced healthcare materials · 2026Review
- Decoding autoimmune disease with single-cell immune repertoire and transcriptome sequencing: mechanisms and therapeutic opportunities.Frontiers in immunology · 2026Review
- Multifaceted Roles of IL-26 in Physiological and Pathological Conditions.International journal of molecular sciences · 2025Review
- Identification of disease-specific regulatory networks in prurigo nodularis versus atopic dermatitis through ATAC/RNA single-nucleus profiling.The Journal of allergy and clinical immunology · 2025Article
- Interleukin-10 family cytokines: key regulators and novel therapeutic targets for respiratory diseases.Inflammopharmacology · 2025Review
- Th17 cells with regulatory phenotype are the main IL-17F and IL-26 producers in palmoplantar pustulosis.JCI insight · 2025Article
- The skin microbiome in dermatologic disease.Journal of the American Academy of Dermatology · 2025Review
- Psoriasis.Nature reviews. Disease primers · 2025Review
- Psoriasis harbors multiple pathogenic type 17 T-cell subsets: Selective modulation by risankizumab.The Journal of allergy and clinical immunology · 2025Article
- Psoriasis: A Multidimensional Review of Onset, Progression, Treatment, and the Evolution of Disease Models.Molecular diagnosis & therapy · 2025Review
- Emerging Techniques in Spatial Multiomics: Fundamental Principles and Applications to Dermatology.The Journal of investigative dermatology · 2025Review
- Techniques and analytic workflow for spatial transcriptomics and its application to allergy and inflammation.The Journal of allergy and clinical immunology · 2025Review
- MiR-223 within neutrophil axis promotes Th17 expansion by PI3K-AKT pathway in systemic lupus erythematosus.Arthritis research & therapy · 2025Article
- Immunological control of skin development: from homeostasis to developmental pathologies.Frontiers in immunology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 7 institutions in 4 countries.
Anissa FriesDepartment of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.
Fanny SaidouneDepartment of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.
François KuonenDepartment of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID 0000-0001-6137-7483
Isabelle DupanloupTranslational Data Science Facility, Agora Cancer Research Center, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Nadine FournierTranslational Data Science Facility, Agora Cancer Research Center, Swiss Institute of Bioinformatics, Lausanne, Switzerland.ORCID 0000-0002-9347-7929
Ana Cristina Guerra de SouzaTranslational Data Science Facility, Agora Cancer Research Center, Swiss Institute of Bioinformatics, Lausanne, Switzerland.
Muzlifah HaniffaDepartment of Dermatology and NIHR Newcastle Biomedical Research Centre, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, NE2 4LP, UK.
Feiyang MaDepartment of Dermatology, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-6260-0787
Johann E GudjonssonDepartment of Dermatology, University of Michigan, Ann Arbor, MI, 48109, USA.ORCID 0000-0002-0080-0812
Lennart RoesnerDepartment of Dermatology, Hannover Medical School, Hannover, Germany.ORCID 0000-0001-6651-0458
Yang LiDepartment of Computational Biology for Individualised Medicine, Centre for Individualised Infection Medicine (CiiM), Helmholtz Centre for Infection Research (HZI), Hannover Medical School (MHH), Hannover, Germany.ORCID 0000-0003-4022-7341
Thomas WerfelDepartment of Dermatology, Hannover Medical School, Hannover, Germany.
Curdin ConradDepartment of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland.ORCID 0000-0002-2547-3440
Raphael GottardoBiomedical Data Sciences Center, CHUV, UNIL, and SIB, Lausanne, Switzerland.
Robert L ModlinDivision of Dermatology, Department of Medicine, University of California, Los Angeles, CA, 90095, USA.ORCID 0000-0003-4720-031X
Jeremy Di DomizioDepartment of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland. Jeremy.Di-Domizio@chuv.ch.ORCID 0000-0002-6281-3918
Michel GillietDepartment of Dermatology, CHUV University Hospital and University of Lausanne (UNIL), Lausanne, Switzerland. michel.gilliet@chuv.ch.ORCID 0000-0002-4609-3762
University of Lausanne · CHMedizinische Hochschule Hannover · DESIB Swiss Institute of Bioinformatics · CHUniversity Hospital of Lausanne · CHUniversity of Michigan · USNIHR Newcastle Biomedical Research Centre · GBUniversity of California, Los Angeles · US
Funding
Molecular Analysis of the Host Immune Response in LeprosyR01AI022553 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROBERT L MODLIN · 1989 to 2026
$15.7MTCR GAMMA/DELTA LYMPHOCYTES IN HUMAN SKIN LESIONSR01AR040312 · NIAMS · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MODLIN, ROBERT L · 1990 to 2025
$10.4MUniversity of Michigan Skin Biology and Diseases Resource-based CenterP30AR075043 · NIAMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Johann Eli Gudjonsson · 2019 to 2026
$6.6MNIAID NIH HHS R01 AI022553NIAMS NIH HHS P30 AR075043NIAMS NIH HHS R01 AR040312
Abstract
Interleukin (IL)-26 is a T
Indexed as
PsoriasisTransforming Growth Factor beta1Cell DifferentiationHumansInterleukin-17SkinInterleukin-17Transforming Growth Factor beta1
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.